GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed
Recalled April 30, 2014 · FDA recall D-1246-2014 · GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Hazard
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent. · FDA Class III
Units
189,900 20 ct Vials, 145,068 81 ct Vials
Sold at
U.S. Nationwide
Description
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Product
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
Manufacturer(s)
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →